You can buy or sell JAZZ and other stocks, options, ETFs, and crypto commission-free!
Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. Read More The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Dublin, Ireland.
52 Week High
52 Week Low
$3.59 per share
$4.10 per share